A 33-year-old woman has revealed her technique to avoid the dreaded saggy skin that comes with the amazing slimming power of revolutionary weight-loss jabs.
‘Foxy’, a singer and musician from Edinburgh, started using the injection Mounjaro in 2024.
Over the course of just 12 months, she lost a whopping 8.5st and achieved a jaw-dropping transformation.
While the drug—dubbed the ‘King Kong’ of weight-loss jabs due to its potency—has been hailed for transforming the lives of patients, many report this has come at a price.
Multiple users have reported ‘saggy skin’, pouches of fatty flesh, or even looking like a ‘melted welly’ after losing so much weight so quickly.
But Foxy said she managed to avoid this known pitfall of taking these drugs—collectively known as GLP-1s—by taking up weightlifting.
Posting a clip of herself at the gym on TikTok she quoted those who warn against taking weight-loss jabs, writing: ‘”Don’t take that stuff you’ll lose all your muscles, have loads of saggy skin and end up with no shape”.’
She than added: ‘Me at the gym proving them wrong.’
‘Foxy’, a singer and musician from Edinburgh, started using the injection Mounjaro in 2024
Over the course of just 12 months she lost a whopping 8.5st (54.5kg) and achieved a jaw-dropping transformation
Expanding on this, Foxy added: ‘Lifting heavy weights is helping me sculpt my body alongside using a GLP1 medication to achieve sustainable, slow, and healthy fat-loss.’
‘Now I’m starting to see the initial results of the work I have put in to my body recomposition, and I’m so glad I lifted weights throughout my journey.’
Foxy did report having some issues with a ‘turkey neck’ and ‘loose skin’ at some points during her weight loss journey, after she lost 100lbs.
In one, clip, which has now been viewed 210,000 times. she said: ‘At certain angles and in certain lights, you can see a bit of a turkey neck forming.’
And she’s also shared some other unexpected downsides of using Mounjaro such as her ‘Botox wearing off faster’ and all her old shoes no longer fitting her.
An estimated 1.5million Britons and some 15 million patients in the US are now thought to be using weight-loss jabs.
Mounjaro has been available in some clinics in the NHS since March but, as last month, GPs are now also able to prescribe it.
The jab, and similar medications, work by mimicking a hormone released by the gut after eating called GLP-1 that suppress appetite and helps people slim down.
Increasing access to these drugs is one of one the cornerstones of the 10-year-plan for the NHS.
While hailed as revolutionary for the fight against obesity, GLP-1 medications, like any drug, come with the risk of side effects, some potentially deadly.
Last month, the UK medicines regulator launched a probe into the safety of fat jabs after hundreds of users developed pancreatitis, a dangerous inflammation of the pancreas, leaving 10 dead.
Of the 10 fatalities, five were connected to Mounjaro.
